Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Same Nicotine Content Cigarettes refer to the control arm intervention in clinical research conducted by the Milton S. Hershey Medical Center (Penn State) investigating tobacco dependence. These research-grade cigarettes, typically from the SPECTRUM line, contain a standardized 'usual' nicotine level of approximately 11.6 mg per cigarette. They are used as a comparator against Reduced Nicotine Content (RNC) cigarettes to evaluate whether tapering nicotine levels can reduce dependence in smokers, particularly those from low socioeconomic backgrounds. The active component, nicotine, is a small molecule that functions as an agonist at nicotinic acetylcholine receptors (nAChRs), primarily the alpha-4-beta-2 subtype, which mediates the addictive properties of tobacco through the mesolimbic dopamine pathway. This research is part of tobacco regulatory science aimed at informing potential FDA regulations on nicotine levels in commercial tobacco products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Same Nicotine Content Cigarettes.